AViTA Corporation (TPEX:4735)
Taiwan · Delayed Price · Currency is TWD 30.85
-0.45 (-1.44%)
At close: Mar 27, 2026
AViTA Revenue
In the year 2025, AViTA had annual revenue of 936.39M TWD with 0.98% growth. AViTA had revenue of 248.05M in the quarter ending December 31, 2025, with 18.96% growth.
Revenue
936.39M
Revenue Growth
+0.98%
P/S Ratio
1.27
Revenue / Employee
11.15M
Employees
84
Market Cap
1.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 936.39M | 9.09M | 0.98% |
| Dec 31, 2024 | 927.30M | 48.22M | 5.48% |
| Dec 31, 2023 | 879.08M | -321.84M | -26.80% |
| Dec 31, 2022 | 1.20B | -1.12B | -48.35% |
| Dec 31, 2021 | 2.33B | -274.96M | -10.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.80B |
| Cowealth Medical Holding | 3.41B |
| OK Biotech | 1.56B |
| Bioptik Technology Incorporation | 837.19M |
| Diamond Biotechnology | 698.11M |
| Radiant Innovation | 387.58M |
| Wiltrom | 311.77M |
| Taiwan Biomaterial | 220.40M |